Peleman R A, Peetermans W E, Van Laethem Y, Bachez P G, Vanatoru J, Van Wassenhove K, Struelens M J, Verhaegen J L
Dept. Internal Medicine, University Hospital Ghent, Belgium.
Acta Clin Belg. 1999 Dec;54(6):321-7. doi: 10.1080/17843286.1999.11754255.
An ad hoc working party on pneumococcal vaccine with representatives of the Belgian Society for Infectiology and Clinical Microbiology, the Belgian Society of Pulmonology and Scientific Societies of General Practitioners reviewed new data on the epidemiology of S. pneumoniae infections in Belgium, on the efficacy and the cost-effectiveness of the 23-valent capsular polysaccharide vaccine. We discuss recent data on vaccination with a new conjugate pneumococcal vaccine, shown to be highly effective in children. The Working Group of the Belgian Scientific Societies endorses the recommendations issued by the Hoge Gezondheidsraad in 1993 and described in a consensus report in 1996.
一个由比利时传染病学与临床微生物学协会、比利时肺病学协会以及全科医生科学协会代表组成的肺炎球菌疫苗特别工作小组，审查了比利时肺炎链球菌感染流行病学的新数据、23价荚膜多糖疫苗的疗效和成本效益。我们讨论了一种新型结合肺炎球菌疫苗接种的最新数据，该疫苗在儿童中显示出高效性。比利时科学协会工作组认可了1993年由荷兰卫生委员会发布并在1996年一份共识报告中描述的建议。
